Insulet
(Nasdaq: PODD)
announced today that it appointed Ana Maria Chadwick as its new EVP, CFO and treasurer.
Chadwick’s appointment — which goes into effect on April 22, 2024 — follows an extensive search process conducted by Insulet. That search spanned nearly six months after former CFO Wayde McMillan left for 3M’s Solventum healthcare spinoff in October.
Lauren Budden served as interim CFO and treasurer following McMillan’s departure. Insulet plans for her to continue in her role as group VP, chief accounting officer and controller.
Chadwick now joins Acton, Massachusetts-based Insulet, a developer of automated insulin delivery technology, with more than 30 years of experience in propelling growth within organizations.
Get the full story at our sister site, Drug Delivery Business News.